USPTO serial 99536260
SHERPA
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHOURI, SANI PHILIPPE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with SHERPA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna H. Hartman
Donna H. Hartman OlenderFeldman LLP422 Morris AvenueSummit, NJ 07901United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials and medical research, namely, providing information management services and management and compilation of computerized databases in the field of clinical trials and medical research for business purposes; Business consulting and management in the field of clinical trials, namely, development of electronic health record orders on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research and clinical trials for drug approval; Business planning, development and project management of medical clinical trials and research. | ACTIVE | — |
| 042 | Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) solutions featuring software for use in managing data and information in the field of medical clinical trials and research; Medical and scientific research, namely, conducting clinical trials; Clinical trial protocol development in the nature of developing protocols for medical clinical trials and research; Clinical trial planning and management in the nature of assisting with the development of orders within an electronic health record system for medical clinical trials; Providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, clinical trial protocol development, clinical trial planning and management, clinical trial user and learning management; Providing online non-downloadable software for developing clinical trial protocols, trial planning and management, and electronic orders for electronic health record systems for clinical trials and research; Providing online non-downloadable software for managing, gathering, organizing, and sharing data, information, and images in the fields of medical clinical trials and medical research, namely, designing, managing, and executing clinical trials and medical research; Providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, for clinical trial protocol development, clinical trial planning and management, clinical trial user and learning management; Providing online non-downloadable software to assist others in operationalizing protocols for drug studies; Software as a service (SaaS) services featuring software using artificial intelligence to improve the design and operational efficiency of clinical trials by means of generating electronic orders within an electronic health record system and extracting structured and unstructured data from clinical trial protocols to create electronic orders within an electronic health record system for clinical trials and medical research; Software as a service (SaaS) services featuring software using artificial intelligence to enable research study startup workflows that digitize electronic orders consistent with clinical trial protocols for electronic health record systems for accelerated initiation of research sites | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Precision Medicine Group, LLC
- Other trademarks owned by Precision Medicine Group, LLC
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named SHERPA
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2025 | NWAP | NEW APPLICATION ENTERED | — |